Dana-Farber appoints chief clinical access and equity officer
Click Here to Manage Email Alerts
Christopher Lathan, MD, MS, MPH, has been appointed chief clinical access and equity officer at Dana-Farber Cancer Institute.
He will be responsible for leading systemwide efforts to combat structural racism and improve health care outcomes by implementing initiatives to reduce disparities in access. He also will work with community leaders to address key challenges.
“By establishing this new leadership role with a champion for equity like Chris, I know we can make real progress to eliminate disparities and make sure nothing stands between lifesaving cancer care and everyone who needs it,” Laurie H. Glimcher, MD, president and CEO of Dana-Farber, said in a press release.
Lathan joined Dana-Farber’s thoracic oncology program in 2005. He was appointed the first faculty director of cancer care equity in 2010. He directs the clinical service at Whittier Street Health Center. He also serves as medical director for Dana-Farber Cancer Institute in Brighton, associate medical director for Dana-Farber Network and assistant professor of medicine at Harvard Medical School.
“This is a great opportunity to directly impact cancer care for underserved patients throughout our institution,” Lathan said in the release. “We are looking forward to continuing to innovate and integrate our efforts with our community partners locally and beyond.”
Click Here to Manage Email Alerts